|
eNovator for Business Development Managers
Business
development including strategic alliances are
more important than ever to intellectual property intense industries
such as the pharmaceutical and biotechnology
industries. Due to their high degree of uncertainty, research
alliances are particularly prone to relationship problems and missed
opportunities for innovation. To maximize the chances of success,
individuals and teams involved in the collaboration need to
be equipped with the appropriate processes, tools, and skills to
manage the day-to-day working relationship. eNovator, the Collaborative eR&D
framework developed by KineMatik™ is perfect for overcoming those
challenges with a full range of scientific and business tools for
ensuring effective collaboration. It represents a new paradigm for
managing strategic alliances enabling the effective portfolio
management of research programs and efficient scientific
collaboration.
eNovator™ is a tool for improving pharmaceutical
alliances with built-in Portfolio Management and Electronic Lab
Notebook (ELN) capabilities. With eNovator,
alliance partners can give their science — and their research
alliances — the best chance for success. The
eNovator solution provides the following benefits to business
development managers for managing IP portfolio and strategic
alliances:
|
Feature
|
Description
|
Benefit
|
|
Electronic Lab
Notebook
|
A fully functional Electronic Laboratory Notebook (ELN) that replaces the paper lab notebook. All experimental results and data are capture electronically.
|
Fast search, data mining and
easy sharing and access to all
experiment data.
|
|
Knowledge
Management
|
The underlying Knowledge
Management (KM) system is
completely web based and offers
common KM functionality such as
document management, collaborative
sharing and discussion groups.
|
One system for all R&D KM &
collaboration requirements. Can be
accessed securely from any location.
|
|
Portfolio Management
|
Built-in Portfolio Management tools
incorporate gating criteria and
performance metrics including cost,
time and risks that are pulled directly
from the research labs and reported
to management for close monitoring.
|
Allows for IP portfolio management,
performance monitoring and just-in-time
decision making.
|
|
